About this toolkit

Stephanie McNairney - National Improvement Advisor. stephanie.mcnairney@nhs.scot

Content has been checked for accessibility in line with the relevant RDS standard operating procedure.

The Specialty Delivery Group have responsibility for ensuring that all content is in line with current best practice and clinical guidance.

The National Improvement Advisor and the PMO at CfSD are responsible for facilitating review and ensuring that content is up to date.

Any amendments are required to be approved by the SDG. The SDG are also responsible for keeping up to date with changes in guidance or best practice and instigating review and amendments if required, between review periods.

The content has been reviewed by the national clinical lead for vascular services and determined to be clinically accurate.

All content has been checked for copyright compliance.

Icons are sourced from Flaticon.com, accessed through the licence held by Tactuum Ltd as software provider of the RDS platform. 

Each new pathway has a Pathway Development Group established. This group is responsible for pathway development, including a literature review of evidence/research/published guidance.

The group is comprised of usually multi-disciplinary clinicians from across the country, who have expertise in the topic. Their professional knowledge and experience is also taken into account.

Feedback should be submitted through the feedback link in the RDS site/app. This is submitted to the RDS team, and from there, they would link with the app content (generally the NIA). This person would work with the RDS team to resolve any issues where possible, and be escalated if appropriate. Escalation may be to the clinical lead, or via the CfSD management team, as appropriate.

All content has been approved by the following governance groups to ensure its accuracy and to mitigate any risks to patient safety:

• AAA/CLTI/VLU Pathway Development Groups
• Vascular Surgery Specialty Delivery Group (SDG)
• Primary Care Secondary Care Interface Delivery Group
• CfSD Sign Off Group.

This toolkit has been assessed as relatively low risk, particularly as the toolkit is not classified as a medical device and does not store person identifiable data. Regardless, the team keeps a hazard log to identify any new risks which may emerge as the toolkit is made live and is updated.

User testing has been conducted to assure usability, navigation, readability, and appropriate formatting.